Annual Retained Earnings
-$722.81 M
-$164.57 M-29.48%
December 31, 2023
Summary
- As of February 26, 2025, SYRS annual retained earnings is -$722.81 million, with the most recent change of -$164.57 million (-29.48%) on December 31, 2023.
- During the last 3 years, SYRS annual retained earnings has fallen by -$345.79 million (-91.72%).
- SYRS annual retained earnings is now -2950.46% below its all-time high of -$23.70 million, reached on December 31, 2014.
Performance
SYRS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$756.24 M
-$6.40 M-0.85%
September 30, 2024
Summary
- As of February 26, 2025, SYRS quarterly retained earnings is -$756.24 million, with the most recent change of -$6.40 million (-0.85%) on September 30, 2024.
- Over the past year, SYRS quarterly retained earnings has stayed the same.
- SYRS quarterly retained earnings is now -1313.19% below its all-time high of -$53.51 million, reached on December 31, 2015.
Performance
SYRS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
SYRS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.5% | 0.0% |
| 3 y3 years | -91.7% | -29.9% |
| 5 y5 years | -232.3% | -29.9% |
SYRS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.9% | at low | -63.1% | at low |
| 5 y | 5-year | -146.7% | at low | -158.1% | at low |
| alltime | all time | -2950.5% | at low | -1313.2% | at low |
Syros Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$756.24 M(+0.9%) |
| Jun 2024 | - | -$749.84 M(+3.2%) |
| Mar 2024 | - | -$726.51 M(+0.5%) |
| Dec 2023 | -$722.81 M(+29.5%) | -$722.81 M(+9.8%) |
| Sep 2023 | - | -$658.42 M(+6.5%) |
| Jun 2023 | - | -$618.28 M(+6.2%) |
| Mar 2023 | - | -$582.02 M(+4.3%) |
| Dec 2022 | -$558.23 M(+20.4%) | -$558.23 M(+0.9%) |
| Sep 2022 | - | -$553.46 M(+5.8%) |
| Jun 2022 | - | -$523.21 M(+7.1%) |
| Mar 2022 | - | -$488.73 M(+5.4%) |
| Dec 2021 | -$463.58 M(+23.0%) | -$463.58 M(+5.4%) |
| Sep 2021 | - | -$439.77 M(+6.3%) |
| Jun 2021 | - | -$413.74 M(+5.7%) |
| Mar 2021 | - | -$391.25 M(+3.8%) |
| Dec 2020 | -$377.02 M | -$377.02 M(+8.7%) |
| Sep 2020 | - | -$346.89 M(+6.0%) |
| Jun 2020 | - | -$327.40 M(+5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$310.21 M(+5.9%) |
| Dec 2019 | -$292.98 M(+34.7%) | -$292.98 M(+7.2%) |
| Sep 2019 | - | -$273.25 M(+7.8%) |
| Jun 2019 | - | -$253.46 M(+8.3%) |
| Mar 2019 | - | -$234.01 M(+7.6%) |
| Dec 2018 | -$217.54 M(+40.1%) | -$217.54 M(+9.0%) |
| Sep 2018 | - | -$199.51 M(+8.6%) |
| Jun 2018 | - | -$183.78 M(+8.3%) |
| Mar 2018 | - | -$169.73 M(+9.3%) |
| Dec 2017 | -$155.27 M(+53.3%) | -$155.27 M(+10.9%) |
| Sep 2017 | - | -$139.96 M(+11.0%) |
| Jun 2017 | - | -$126.14 M(+11.9%) |
| Mar 2017 | - | -$112.77 M(+11.4%) |
| Dec 2016 | -$101.26 M(+89.2%) | -$101.26 M(+12.1%) |
| Sep 2016 | - | -$90.29 M(+18.6%) |
| Jun 2016 | - | -$76.12 M(+17.4%) |
| Mar 2016 | - | -$64.83 M(+21.1%) |
| Dec 2015 | -$53.51 M(+125.8%) | -$53.51 M |
| Dec 2014 | -$23.70 M | - |
FAQ
- What is Syros Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual retained earnings year-on-year change?
- What is Syros Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly retained earnings year-on-year change?
What is Syros Pharmaceuticals annual retained earnings?
The current annual retained earnings of SYRS is -$722.81 M
What is the all time high annual retained earnings for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual retained earnings is -$23.70 M
What is Syros Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, SYRS annual retained earnings has changed by -$164.57 M (-29.48%)
What is Syros Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of SYRS is -$756.24 M
What is the all time high quarterly retained earnings for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly retained earnings is -$53.51 M
What is Syros Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, SYRS quarterly retained earnings has changed by $0.00 (0.00%)